OrthoPediatrics Corp.

23.58
-2.73 (-10.38%)
At close: Apr 03, 2025, 3:59 PM
24.43
3.60%
After-hours: Apr 03, 2025, 05:49 PM EDT

Company Description

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally.

The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system.

The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers.

OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

OrthoPediatrics Corp.
OrthoPediatrics Corp. logo
Country United States
IPO Date Oct 13, 2017
Industry Medical - Devices
Sector Healthcare
Employees 562
CEO David R. Bailey

Contact Details

Address:
2850 Frontier Drive
Warsaw, Indiana
United States
Website https://www.orthopediatrics.com

Stock Details

Ticker Symbol KIDS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001425450
CUSIP Number 68752L100
ISIN Number US68752L1008
Employer ID 26-1761833
SIC Code 3841

Key Executives

Name Position
David R. Bailey President, Chief Executive Officer & Director
Fred L. Hite Chief Financial Officer, Principal Financial & Accounting Officer, Chief Operating Officer and Director
Daniel J. Gerritzen J.D. Executive Vice President of Legal, General Counsel & Secretary
Gregory A. Odle President of Scoliosis
Joseph W. Hauser President of Trauma & Deformity Correction
Kevin L. Unger CHE, MBA/MSHA President of Enabling Technologies
Mark Karshner Senior Vice President of International Sales
Mark C. Throdahl Executive Chairman
Ray Garrison Senior Vice President of Quality & Regulatory and Clinical

Latest SEC Filings

Date Type Title
Apr 02, 2025 ARS Filing
Apr 02, 2025 DEFA14A Filing
Apr 02, 2025 DEF 14A Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 06, 2025 8-K Current Report
Mar 05, 2025 10-K Annual Report